Ticker Details
Tempest Therapeutics, Inc.
IPO Date:	December 7, 2012
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$11.83M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 4.91%
Avg Daily Range (30 D):	$0.09 | 3.58%
Avg Daily Range (90 D):	$0.22 | 3.95%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.2M

Trade Size
Avg Trade Size (Sh.):	94
Avg Trade Size (Sh.) (30 D):	157
Avg Trade Size (Sh.) (90 D):	218

Institutional Trades
Total Institutional Trades:	58
Avg Institutional Trade:	$1.06M
Avg Institutional Trade (30 D):	$.82M
Avg Institutional Trade (90 D):	$.82M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.29M
Avg Closing Trade (30 D):	$1.31M
Avg Closing Trade (90 D):	$1.31M
Avg Closing Volume:	23.51K

News

Nov 19, 2025 @ 2:00 PM Tempest Announces Strategic Acquisition of New Dua... Source: Globe Newswire

Nov 19, 2025 @ 2:00 PM Tempest Announces Strategic Acquisition of New Dua... Source: Tempest Therapeutics

Sep 25, 2025 @ 5:00 PM Advanced Liver Cancer Clinical Trial Pipeline Show... Source: Delveinsight

Feb 7, 2025 @ 9:30 PM Tempest Reports Inducement Grant Under Nasdaq List... Source: N/A

Jan 6, 2025 @ 1:00 PM Tempest Receives Orphan Drug Designation from the ... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$8.02	$-.79	$-2.07
Diluted EPS	$8.02	$-.79	$-2.07
Revenue
Gross Profit
Net Income / Loss	$-36.05M	$-3.51M	$-7.87M
Operating Income / Loss	$-36.42M	$-3.6M	$-7.97M
Cost of Revenue
Net Cash Flow	$7.8M	$M	$M
PE Ratio	0.31

Splits
Jan 30, 2026	2:1
Apr 09, 2025	1:13
Jun 28, 2021	1:15